POU6F2-AS1
gene geneOn this page
Summary
POU6F2-AS1 (POU6F2 antisense RNA 1, HGNC:40979) is a long non-coding RNA gene on chromosome 7p14.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:40979 |
| Approved symbol | POU6F2-AS1 |
| Name | POU6F2 antisense RNA 1 |
| Location | 7p14.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000224122 |
| Ensembl biotype | lncRNA |
| Entrez | 100861520 |
| RNAcentral | URS000075DDF6 — lncRNA, 393 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 lncRNA
ENST00000433519, ENST00000653564, ENST00000663864, ENST00000729145, ENST00000729146, ENST00000729147
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000433519 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001631904 | 39404598 | 39404783 |
| ENSE00001646438 | 39406017 | 39406119 |
| ENSE00001699780 | 39404927 | 39405005 |
| ENSE00004056391 | 39406334 | 39406414 |
Expression profiles
Bgee: expression breadth broad, 73 present calls, max score 83.10.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0286 / max 5.6983, expressed in 17 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 83718 | 0.0286 | 17 |
Top tissues by expression
73 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.10 | silver quality |
| muscle tissue | UBERON:0002385 | 71.69 | gold quality |
| liver | UBERON:0002107 | 71.43 | gold quality |
| right lobe of liver | UBERON:0001114 | 71.02 | gold quality |
| ganglionic eminence | UBERON:0004023 | 65.85 | gold quality |
| islet of Langerhans | UBERON:0000006 | 65.61 | gold quality |
| gall bladder | UBERON:0002110 | 65.07 | gold quality |
| body of stomach | UBERON:0001161 | 64.98 | gold quality |
| stomach | UBERON:0000945 | 64.33 | gold quality |
| fundus of stomach | UBERON:0001160 | 62.90 | gold quality |
| blood | UBERON:0000178 | 59.41 | gold quality |
| duodenum | UBERON:0002114 | 58.26 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 56.75 | gold quality |
| pancreas | UBERON:0001264 | 56.72 | gold quality |
| kidney | UBERON:0002113 | 56.56 | gold quality |
| intestine | UBERON:0000160 | 55.49 | gold quality |
| monocyte | CL:0000576 | 54.03 | gold quality |
| cortex of kidney | UBERON:0001225 | 52.97 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 52.82 | gold quality |
| prefrontal cortex | UBERON:0000451 | 52.72 | gold quality |
| multicellular organism | UBERON:0000468 | 51.73 | gold quality |
| primary visual cortex | UBERON:0002436 | 50.75 | gold quality |
| ascending aorta | UBERON:0001496 | 50.06 | gold quality |
| thoracic aorta | UBERON:0001515 | 50.05 | gold quality |
| gastrocnemius | UBERON:0001388 | 49.68 | gold quality |
| colon | UBERON:0001155 | 49.09 | gold quality |
| left testis | UBERON:0004533 | 49.07 | gold quality |
| testis | UBERON:0000473 | 48.62 | gold quality |
| right testis | UBERON:0004534 | 48.00 | gold quality |
| body of pancreas | UBERON:0001150 | 47.78 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.86 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- The m[6]A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN. (PMID:38491348)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.